A. Bárczi

发表

Follow-Up of Blood Pressure, Arterial Stiffness, and GFR in Pediatric Kidney Transplant Recipients

A. Szabó, A. Végh, E. Kis, 2021, Frontiers in Medicine.

SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes

A. Szabó, L. Wagner, A. Fekete, 2022, PloS one.

Novel therapeutic potential of angiotensin receptor 1 blockade in a rat model of diabetes-associated depression parallels altered BDNF signalling

T. Farkas, Á. Dénes, K. Szigeti, 2019, Diabetologia.

Subclinical cardiac dysfunction in pediatric kidney transplant recipients identified by speckle-tracking echocardiography

B. Merkely, P. Salvi, E. Kis, 2022, Pediatric Nephrology.